Citra Labs, LLC
55 Messina Drive
Braintree, MA 02184 USA
ACD-A Anticoagulant Citrate Dextrose Solution, Solution A, USP (2.13% free citrate ion), is a sterile, non-pyrogenic solution. ACD-A is the only anticoagulant product approved by the United States Food & Drug Administration (FDA) for the use in Autologous PRP Systems for the preparation of Platelet-Rich Plasma (PRP).
Procedures
Application
Technology
ACD-A Anticoagulant Citrate Dextrose Solution, Solution A, USP (2.13% free citrate ion), is a sterile, non-pyrogenic solution.
Citrate-based anticoagulants prevent the coagulation of blood by virtue of the citrate ion's ability to chelate ionized calcium present in the blood to form a non-ionized calcium-citrate complex.
Anticoagulant approved by the FDA
Warnings and Contraindications
Adverse Reactions
All content herein is protected by copyright, trademarks and other intellectual property rights, as applicable, owned by or licensed to Zimmer Biomet or its affiliates unless otherwise indicated, and must not be redistributed, duplicated or disclosed, in whole or in part, without the express written consent of Zimmer Biomet.
This material is intended for health care professionals. Distribution to any other recipient is prohibited.
For product information, including indications, contraindications, warnings, precautions, potential adverse effects and patient counseling information, see the package insert or contact your local representative; search this website for additional product information. To obtain a copy of the current Instructions for Use (IFU) for full prescribing and risk information, please call 1-800-348-2759, press 4 for 411 Technical Support.